Clinical Research Directory
Browse clinical research sites, groups, and studies.
Simethicone as Part of ERAS in Bariatric Surgery Patients
Sponsor: Madigan Army Medical Center
Summary
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Official title: Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol
Key Details
Gender
All
Age Range
18 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2025-04-08
Completion Date
2029-03
Last Updated
2025-06-15
Healthy Volunteers
Yes
Interventions
Simethicone 80 MG
Patients will receive simethicone 80mg four times per day for 2 weeks post-operatively.
Placebo
Patients in the control group will receive a placebo pill four times per day for 2 weeks
Locations (1)
Madigan Army Medical Center
Tacoma, Washington, United States